Study To Determine Efficacy of Aflibercept For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration

Trial Profile

Study To Determine Efficacy of Aflibercept For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2015

At a glance

  • Drugs Aflibercept (Primary)
  • Indications Age-related macular degeneration; Choroidal neovascularisation; Retinal haemorrhage; Retinal oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top